APTEVO PENNIESTOCK. BUY 2m mcap, penniestock buy now.
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−941.56 USD
−17.41 M USD
0.00 USD
1.46 M
About Aptevo Therapeutics Inc.
Sector
Industry
CEO
Marvin L. White
Website
Headquarters
Seattle
Founded
2016
FIGI
BBG009RRZ8C2
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.
APVO - Swing/Gap PlayThis ticker has seen wild pops in the past off news. Setup seems poised for a breakout and the company is due to announce clinical updates in the next 3-4 months. Notice the obvious gap to fill at .95, as this could make for an interesting swing play at current price levels.
Compelling Long TradeGreetings, fellow traders! Today, I am thrilled to present an exciting and potentially lucrative long trade opportunity that combines various compelling factors. This trade idea is backed by the convergence of three drives lower, favorable fundamentals, three consecutive days of lower prices, and th
IBS SQUEEZEE ON $APVO Inside bar squeeze super simple set up day 1 is the big move day 2 is the day that's down 50% ish then day 3 is the parabolic move
approaching important support, make it or break it area 🍿apvo is approaching a few big support areas. I wouldn't hold if it broke below.
theres a few outcomes if we bounce off the support, first one is we rally to the 12.5-13.5 top trendline resistance then get rejected back to lows...
second outcome is it breaks that big trendline resistance and has a
$APVOAptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinic
$APVOJust broke out of falling wedge along horizontal support.
Daily hidden bullish divergence on the MACD.
Hidden bullish divergence confirmed on the 4hr MACD and RSI
Weekly hidden bullish divergence could develop on the MACD.
Stop (1st Target) = Under horizontal support
Stop (2nd Target) = Below g
$APVO BUY signal with 7 confirmationsAptevo Therapeutics is quietly changing their downward trend to positive.
BUY signal with 7 confirmations. Only thing missing is above average volume but part of it is Reddit and Twitter world is not talking about it.
Happy Trading, from CJ -- aka the greatest FURU.
To find out more about The Ul
beginning of the 3rd wave mapping the elliot wave theory i'm showing the possible beginning of the 3rd wave in the impulse wave .
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of APVO is 4.87 USD — it has decreased by −0.21% in the past 24 hours. Watch Aptevo Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aptevo Therapeutics Inc. stocks are traded under the ticker APVO.
APVO stock has risen by 7.62% compared to the previous week, the month change is a −61.34% fall, over the last year Aptevo Therapeutics Inc. has showed a −98.40% decrease.
We've gathered analysts' opinions on Aptevo Therapeutics Inc. future price: according to them, APVO price has a max estimate of 21.00 USD and a min estimate of 21.00 USD. Watch APVO chart and read a more detailed Aptevo Therapeutics Inc. stock forecast: see what analysts think of Aptevo Therapeutics Inc. and suggest that you do with its stocks.
APVO reached its all-time high on Jul 27, 2016 with the price of 188,945.68 USD, and its all-time low was 3.65 USD and was reached on Dec 16, 2024. View more price dynamics on APVO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
APVO stock is 6.35% volatile and has beta coefficient of 2.36. Track Aptevo Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Aptevo Therapeutics Inc. there?
Today Aptevo Therapeutics Inc. has the market capitalization of 7.02 M, it has increased by 12.82% over the last week.
Yes, you can track Aptevo Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Aptevo Therapeutics Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
APVO earnings for the last quarter are −17.76 USD per share, whereas the estimation was −21.09 USD resulting in a 15.79% surprise. The estimated earnings for the next quarter are −7.75 USD per share. See more details about Aptevo Therapeutics Inc. earnings.
Aptevo Therapeutics Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
APVO net income for the last quarter is −5.10 M USD, while the quarter before that showed −5.88 M USD of net income which accounts for 13.29% change. Track more Aptevo Therapeutics Inc. financial stats to get the full picture.
No, APVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 40.00 employees. See our rating of the largest employees — is Aptevo Therapeutics Inc. on this list?
Like other stocks, APVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aptevo Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aptevo Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aptevo Therapeutics Inc. stock shows the sell signal. See more of Aptevo Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.